First, we evaluated the levels of expression of Wee1 mRNA in a cohort of 58 ALL primary samples, and then the effectiveness of AZD-1775, as monotherapy and in combination with different drugs normally used as a standard of care for adult ALL patients. Here, WEE1 is linked to acute lymphoblastic leukemia.